Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy
CardioRenal Medicine- Switzerland
doi 10.1159/000342968
doi 10.1159/000342968